# Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19

> **NCT06676709** · PHASE1,PHASE2 · COMPLETED · sponsor: **Universidad Autonoma de Nuevo Leon** · enrollment: 80 (actual)

## Conditions studied

- COVID-19
- SARS-CoV2 Infection

## Interventions

- **BIOLOGICAL:** IMMUNEPOTENT-CRP (I-CRP)
- **BIOLOGICAL:** Placebo Comparator

## Key facts

- **NCT ID:** NCT06676709
- **Lead sponsor:** Universidad Autonoma de Nuevo Leon
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-20
- **Primary completion:** 2022-02-03
- **Final completion:** 2022-03-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-11-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06676709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06676709, "Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06676709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*